Cipla Pharma And Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 275.00 Cr
as on 06-07-2024
- Paid Up Capital ₹ 258.71 Cr
as on 06-07-2024
- Company Age 16 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 27.60%
(FY 2021)
- Profit -31.57%
(FY 2021)
- Ebitda 8.84%
(FY 2021)
- Net Worth -7.40%
(FY 2021)
- Total Assets -11.97%
(FY 2021)
About Cipla Pharma And Life Sciences
The Corporate was formerly known as Mabpharm Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 275.00 Cr and a paid-up capital of Rs 258.71 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Cipla Pharma And Life Sciences Limited India are Deepraj Desai as CFO and Akshaya Kolvankar as Company Secretary. Rajendra Chopra, Anisha Udeshi, Achin Gupta, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24239MH2008PLC381559
- Company No.
007374
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
20 Aug 2008
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
South Goa, Goa, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Cipla Pharma And Life Sciences?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sunil Gupta | Managing Director | 02-Feb-2024 | Current |
| Deepraj Desai | CFO | 07-Feb-2019 | Current |
| Akshaya Kolvankar | Company Secretary | 15-Jul-2019 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anisha Udeshi  | Director | 08-Jun-2020 | Current |
| Rajendra Chopra | Director | 02-Jan-2019 | Current |
| Achin Gupta | Director | 14-Feb-2024 | Current |
| Jinesh Chauhan | Whole-Time Director | 01-Apr-2023 | Current |
Financial Performance and Corporate Structure Insights of Cipla Pharma And Life Sciences.
Cipla Pharma And Life Sciences Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 27.6% increase. The company also saw a substantial fall in profitability, with a 31.57% decrease in profit. The company's net worth dipped by a decrease of 7.4%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cipla Pharma And Life Sciences?
In 2022, Cipla Pharma And Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Goldencross Pharma LimitedActive 24 years 11 monthsRajendra Chopra and Anisha Udeshi are mutual person
- Cipla Pharmaceuticals LimitedActive 5 years 1 month
Rajendra Chopra and Anisha Udeshi are mutual person
- Cipla Digital Health LimitedActive 2 years 9 months
Rajendra Chopra, Anisha Udeshi and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Cipla Pharma And Life Sciences?
Cipla Pharma And Life Sciences has a workforce of 28 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cipla Pharma And Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cipla Pharma And Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
